Items Tagged ‘VeriStrat test’

June 25th, 2015

Aetna Provides Coverage for Biodesix’ VeriStrat Test


Biodesix, Inc. announced that its VeriStrat® test is now considered a medically necessary benefit by Aetna Corporation (NYSE: AET).  Aetna published a positive coverage policy for the VeriStrat proteomic test on June 5th, stating the test is medically necessary “for patients with advanced NSCLC, whose tumors were without EGFR and anaplastic lymphoma kinase (ALK) mutations…” Aetna’s […]

View full entry

Tags: health coverage, Lung Cancer - Non-Small Cell, News, non-small cell lung cancer, nsclc, proteomic blood test, Stages IIIB-IV Lung Cancer - Non-Small Cell, VeriStrat test